These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7374998)

  • 41. [Tiopronine: new basic treatment for rheumatoid arthritis. Open study of 158 cases].
    Pasero G; Pellegrini P; Ciompi ML; Colamussi V; Barbieri P; Mazzoni MR
    Rev Rhum Mal Osteoartic; 1980 Mar; 47(3):163-8. PubMed ID: 7384725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Controlled clinical study of the therapeutic activity of arginine thiazolidine carboxylate in patients with chronic toxic and postinfective hepatopathies].
    Salsano F; Ciancarelli MP
    Minerva Dietol Gastroenterol; 1979; 25(4):391-8. PubMed ID: 400006
    [No Abstract]   [Full Text] [Related]  

  • 43. [On the treatment of various liver diseases by oral administration of arginine glucose-1-phosphate].
    Arrigo A
    Clin Ter; 1967 Dec; 43(6):523-41. PubMed ID: 5617980
    [No Abstract]   [Full Text] [Related]  

  • 44. [Histological and ultramicroscopic aspects of the small intestine in aregenerative enteropathies after treatment with 2-mercapto-propionyl-glycine (Thiola)].
    Labò G; Gasbarrini G; Barbara L; Fontana G; Corazza GR
    Minerva Med; 1977 Jul; 68(36):2491-8. PubMed ID: 887228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arginine thiazolidinecarboxylate in the treatment of chronic active hepatitis: double-blind comparison with placebo.
    Miracco A; Iodice G; Peluso C; Quarentelli A; Selce P; Tedesco A; Pastore P
    J Int Med Res; 1984; 12(1):35-9. PubMed ID: 6363155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].
    Abbou R; Mahoudeau D; Dubrisay J; Volteau M
    Sem Hop; 1965 Apr; 41(19):1170-6. PubMed ID: 4284191
    [No Abstract]   [Full Text] [Related]  

  • 47. [Controlled clinical trial of arginine malate associated with cytidine and uridine in secondary hepatopathies].
    Rampazzo F
    Minerva Med; 1974 Feb; 65(15):838-49. PubMed ID: 4826131
    [No Abstract]   [Full Text] [Related]  

  • 48. [Value of tiadilon in hepatobiliary pathology].
    Saigot T
    Med Chir Dig; 1979; 8(6):575-6. PubMed ID: 529858
    [No Abstract]   [Full Text] [Related]  

  • 49. Thiopronine therapy in rheumatoid arthritis.
    Pasero G; Ciompi ML
    Arthritis Rheum; 1979 Jul; 22(7):803-4. PubMed ID: 454510
    [No Abstract]   [Full Text] [Related]  

  • 50. [Changes in the content of certain free amino acids in the blood serum in chronic liver disease under the influence of prednisolone therapy].
    Isakova ZS
    Ter Arkh; 1966 Oct; 38(10):80-4. PubMed ID: 5999185
    [No Abstract]   [Full Text] [Related]  

  • 51. [Arginine thiazolidinecarboxylate poisoning].
    Marcos Sánchez F; Contreras Rosino C; Moreiras Jiménez JL; Juan Sarmiento E; López Onega P
    Med Clin (Barc); 1987 Jan; 88(2):82. PubMed ID: 3821268
    [No Abstract]   [Full Text] [Related]  

  • 52. [Study of the changes of some biohumoral parameters related to hepatic function. Special reference to the lipid pattern after treatment with alpha-mercaptopropionylglycine in a group of aged subjects].
    Melga PL; Peluffo F; Ghiorzi GB; Campostano A; Derchi L
    Minerva Med; 1980 Sep; 71(32):2273-80. PubMed ID: 7432659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Alpha-mercapto-propionyl-glycine in the treatment of acute viral hepatitis].
    Precchia G; Guerriero M; Tarallo P; Patarino T; Mandia V; Antoniello S
    Minerva Med; 1975 Feb; 66(12):570-4. PubMed ID: 1113907
    [No Abstract]   [Full Text] [Related]  

  • 54. [Contribution to the treatment of chronic liver diseases with Thioctacid].
    Huslarová A; Fric P
    Cesk Gastroenterol Vyz; 1982 Nov; 36(8):422-8. PubMed ID: 6819091
    [No Abstract]   [Full Text] [Related]  

  • 55. [Further clinical observations on the treatment of noncirrhotic alcoholic liver disease].
    Buzzi S; Ghetti C; Sala G
    Ateneo Parmense Acta Biomed; 1980; 51(3):139-45. PubMed ID: 7213456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Protective activity of arginine thiazolidinecarboxylate on potassium depletion induced by phalloidine in the perfused rat liver].
    Falchi M; Nebuloni R; Carminati R; Guadagni L; Lodi G
    Boll Chim Farm; 1978 Dec; 117(12):731-4. PubMed ID: 752355
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effectiveness of S-adenosylmethionine (SAM) in the treatment of chronic liver diseases].
    Silvi G; Rina D; Giannelli G
    Clin Ter; 1980 Feb; 92(3):241-50. PubMed ID: 7449310
    [No Abstract]   [Full Text] [Related]  

  • 58. [Antihepatotoxic activity of arginine thiazolidinecarboxylate in hepatitis induced by galactosamine in the rat].
    Carminati R; Falchi M; Nebuloni R; Guadagni L; Lodi R
    Farmaco Prat; 1979 Apr; 34(4):163-7. PubMed ID: 456554
    [No Abstract]   [Full Text] [Related]  

  • 59. [A trial of using Geptral in patients with chronic liver diseases].
    Gorbakov VV; Kalinin AV; Ermolin SN
    Voen Med Zh; 1996 Dec; 317(12):29-31. PubMed ID: 9163214
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical experience in the treatment of chronic liver diseases with Solcohepsyl extralysate].
    Arias Vallejo E
    Folia Clin Int (Barc); 1966 Sep; 16(9):404-15. PubMed ID: 5990974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.